ロード中...
High incidence of atrial fibrillation in patients treated with ibrutinib
OBJECTIVE: Atrial fibrillation (AF) is one of the most common side effects of ibrutinib, a drug that has dramatically improved the prognosis of chronic B-cell malignancies such as chronic lymphocytic leukaemia (CLL). The true incidence of ibrutinib-related AF (IRAF) is not well known and its therape...
保存先:
| 出版年: | Open Heart |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMJ Publishing Group
2019
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6519413/ https://ncbi.nlm.nih.gov/pubmed/31168393 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/openhrt-2019-001049 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|